These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
36. Novel 5-HT6 receptor antagonists/D2 receptor partial agonists targeting behavioral and psychological symptoms of dementia. Kołaczkowski M; Marcinkowska M; Bucki A; Śniecikowska J; Pawłowski M; Kazek G; Siwek A; Jastrzębska-Więsek M; Partyka A; Wasik A; Wesołowska A; Mierzejewski P; Bienkowski P Eur J Med Chem; 2015 Mar; 92():221-35. PubMed ID: 25557493 [TBL] [Abstract][Full Text] [Related]
37. Targeting GluN2B-containing N-Methyl-D-aspartate receptors: design, synthesis, and binding affinity evaluation of novel 3-substituted indoles. Buemi MR; De Luca L; Ferro S; Gitto R Arch Pharm (Weinheim); 2014 Aug; 347(8):533-9. PubMed ID: 24862313 [TBL] [Abstract][Full Text] [Related]
38. II. Localization and characterization of dopamine D4 binding sites in rat and human brain by use of the novel, D4 receptor-selective ligand [3H]NGD 94-1. Primus RJ; Thurkauf A; Xu J; Yevich E; McInerney S; Shaw K; Tallman JF; Gallagher DW J Pharmacol Exp Ther; 1997 Aug; 282(2):1020-7. PubMed ID: 9262371 [TBL] [Abstract][Full Text] [Related]
39. Design, synthesis, and evaluation of chromen-2-ones as potent and selective human dopamine D4 antagonists. Kesten SR; Heffner TG; Johnson SJ; Pugsley TA; Wright JL; Wise LD J Med Chem; 1999 Sep; 42(18):3718-25. PubMed ID: 10479303 [TBL] [Abstract][Full Text] [Related]
40. Pharmacological and functional characterisation of dopamine D4 receptors in the rat retina. Patel S; Chapman KL; Marston D; Hutson PH; Ragan CI Neuropharmacology; 2003 Jun; 44(8):1038-46. PubMed ID: 12763097 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]